Company / R&D per Share
Actinium Pharmaceuticals, Inc. R&D per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.68
FY2025
5-year range
$0.68 / $1.40
FY2021-FY2025
Trend
-51.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 6 years, ranging from $0.03 in FY2011 to $1.40 in FY2024.
Based on SEC 10-K filings.
0.68 in FY2025 with a 3-year CAGR of -6.0%.
Declined from $0.90 to $0.68 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -6.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 51.6% year-over-year.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2011.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.68 | -51.6% |
| FY2024 | $1.40 | +55.3% |
| FY2023 | $0.90 | +10.7% |
| FY2022 | $0.81 | -11.2% |
| FY2021 | $0.92 | +3060.7% |
| FY2011 | $0.03 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026